Agilent Technologies, Inc. (FRA:AG8)

Germany flag Germany · Delayed Price · Currency is EUR
103.90
-3.12 (-2.92%)
At close: Feb 20, 2026
Market Cap29.51B -27.2%
Revenue (ttm)6.02B +6.7%
Net Income1.13B +1.1%
EPS3.96 +3.2%
Shares Outn/a
PE Ratio26.12
Forward PE20.63
Dividend0.87 (0.84%)
Ex-Dividend DateJan 6, 2026
Volumen/a
Average Volume47
Open107.46
Previous Close107.02
Day's Range103.52 - 107.46
52-Week Range87.00 - 137.98
Betan/a
RSI33.57
Earnings DateFeb 25, 2026

About Agilent Technologies

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti... [Read more]

Industry Laboratory Analytical Instruments
Founded 1999
Employees 18,100
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol AG8
Full Company Profile

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Financial numbers in USD Financial Statements